Philip Wagenheim: Director at Immunome Inc., stock sales and holdings

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

No plan disclosedOne dollar scale for every month; the tallest bar is labeled

What the filings show, past 12 months. Nothing here rates or predicts.

Sold in 1 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026.
Largest single sale: $753K (36,800 shares) of Immunome Inc. on Mar 20, 2026. Filing
No sale on record before this period.

Every company we track where this person has filed, newest filing first.

Company	Title	First filing	Latest filing
Immunome Inc. (IMNM)	Director	Oct 1, 2020	Jun 12, 2026

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

Mar 23, 2026, Immunome Inc.: sold 28,200 shares for $582K, no plan disclosed. 1 filing: 1
Mar 20, 2026, Immunome Inc.: sold 36,800 shares for $753K, no plan disclosed. 1 filing: 1

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.